Nanoparticles’ path from lungs to body illuminates effects of air pollution, offers promise for inhaled drug therapies

Nanoparticles too small to see through a traditional microscope could be used in developing therapeutic agents to treat pulmonary disease, and also offer a greater understanding of the health effects of air pollution, according to scientists from HSPH and Beth Israel Deaconess Medical Center. The researchers used a novel, real-time imaging system to track a group of nanoparticles as they moved from the lungs into the body and out again. Akira Tsuda, a co-author and principal research scientist at HSPH, told The Boston Globe that the paper’s findings, published November 7 in an advance online issue of the journal Nature Biotechnology, provided important new information about how nanoparticles interact in the body.

Read The Boston Globe story

More information

Scientists Chronicle Nanoparticles’ Journey From the Lungs Into the Body (press release)